News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Finance
Media Mogul Rupert Murdoch Dumps $125 Million Theranos Stake for $1 3/27/2017
These Two Drugmakers Have Even More Debt Than Valeant (VRX) 3/27/2017
GE Healthcare to Invest $500 Million and Hire 5,000 Software Engineers 3/27/2017
Twist Bioscience Raises $33 Million 3/27/2017
This Colorado Pharma May Not Have Enough Cash to Last 2017 3/24/2017
Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued 3/24/2017
How This New Jersey Biotech is Taking on Amgen (AMGN) 3/24/2017
Despite Recent Layoffs, Eli Lilly (LLY) to Invest $850 Million in U.S. Operations 3/24/2017
3 Biotechs the Super-Rich Regret Buying in 2017 (So Far) 3/24/2017
5 Biotechs That Have Major Catalysts Coming in the Next 6 to 9 Months 3/24/2017
C-Bridge Capital And Tasly Invest $150 Million In Two China Biopharmas 3/24/2017
Provectus Announces Terms Of Definitive Financing Commitment 3/24/2017
Praesidian Capital Exits Successful $23 Million Investment In PromptCare Companies 3/24/2017
How Biogen (BIIB) Spinoff Bioverativ (BIVVV) and Its Hemophilia Med Could Make This Biotech Bleed 3/23/2017
Filing Shows Money Woes May Force NeuralStem to Halt Trials, Cease Operations or File for Bankruptcy 3/23/2017
5 Biotechs the Super-Rich Are Favoring in 2017 (So Far) 3/23/2017
Mentor Capital Invests First $1.0 Million In G FarmaLabs 3/23/2017
410 Medical Innovation Closes $3.3 Million Initial Investment In Series A Financing 3/23/2017
4 Small-Cap Biotechs to Consider if Gilead (GILD) Isn’t Doing it For You 3/22/2017
Bay Area's BioClin Therapeutics Nabs $30 Million Series B for Bladder Cancer Med 3/22/2017
Biotech Start-Up Upside Biotechnologies Raises $2.3M In Series A Funding Round 3/22/2017
VECT-HORUS Raises 2.5 M€ To Finance Its Development Projects In The "Targeted Therapy" Field 3/22/2017
SYGNIS Anounces Change In Guarantee For Spanish Government Soft Loans 3/22/2017
Valeant Completes Refinancing Transactions 3/22/2017
Q Biomed Completes 2nd Closing On $4,000,000 Funding 3/22/2017
Tyme Announces $8.2 Million Private Placement 3/22/2017
Semma Therapeutics Receives Investment From JDRF T1D Fund 3/22/2017
Medtronic (MDT) Announces Pricing of $2 Billion of Senior Notes 3/22/2017
QT Vascular Scores $14.3 Million Capital 3/22/2017
Colorado's EndoShape Grabs $10.5 Million 3/22/2017
Trump Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals 3/21/2017
Heads Up Investors: 4 Biotechs With A Unique But Promising Product Candidate 3/21/2017
Bay Area's SutroVax Scores $64 Million To Tackle Pneumococcal Vaccines 3/21/2017
Ex-GlaxoSmithKline (GSK) Scientists' Pulmocide Hauls in $30.4 Million 3/21/2017
Sound Pharmaceuticals, Inc. Announces $1.6 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. To Prevent And Treat The Hearing Loss And Tinnitus Associated With Antibiotic Use 3/21/2017
Suzhou Ribo Life Science Co. Ltd. Lands $39 Million B Round For siRNA Portfolio 3/21/2017
Massachusetts' Ivenix Bags $50 Million Financing to Accelerate Growth of Transformative Infusion System 3/21/2017
MYnd Analytics Announces A Strategic One Million Dollar Equity Investment 3/21/2017
Trump's Expected Policy Changes Have Propelled These 2 Biotechs to New Highs 3/20/2017
Biogen (BIIB) Faces Biggest One-Day Drop 3/20/2017
This Cheap Michigan Biotech Could Have Major Phase II Catalysts Coming 3/20/2017
The Hype Behind Massachusetts Biotech Corbus (CRBP)' Sole Pipeline Drug 3/20/2017
Siemens (SI) Supports Power Projects In Bangladesh With Financing 3/20/2017
Provectus Enters Into Definitive Financing Commitment Term Sheet 3/20/2017
Advicenne Announces The Closing Of A €16 Million Financing Round 3/20/2017
EKF diagnostic GmbH Ponders Over Splitting Company in Two 3/20/2017
MedLumics Rakes in $34.4 Million Euros in Series B Funding 3/20/2017
How Bay Area's Invitae's Sales Could Double in 2017 3/20/2017
Major Reorganization to Hit the NIH, Deep Cuts to Affect Thousands Under Trump Budget Plan 3/17/2017
Valeant (VRX) Stock Shows Signs Of Life After ValueAct Buy 3/17/2017
Scientists: 7 Ways How to Avoid Biotech Employers That Are Likely to Go Financially Bust 3/17/2017
This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants 3/17/2017
World's Smartest Billionaire Upped Position in This Bay Area Biotech 3/17/2017
Ex-Google (GOOG) Exec's Stroke Prevention Startup AliveCor Gets $30 Million 3/17/2017
NW Bio (NWBO) Announces Registered Direct Offering Of $7.5 Million 3/17/2017
Bay Area's Livongo Rakes in $52.5 Million 3/17/2017
3 Medtechs That Could Brave and Survive Policy Uncertainty 3/17/2017
Ex-Google (GOOG) Rock Star Decides to Raise $100 Million Biotech Venture Fund After All 3/16/2017
Bay Area VC Firm Pivotal bioVenture Partners Closes $300 Million Life Sciences Fund 3/16/2017
UK Immunotherapy Biotech Cell Medica Rakes in £60 Million to Advance Multiple Cancer Programs 3/16/2017
Akebia (AKBA) Spinoff Aerpio Scores $40 Million 3/16/2017
Aerpio Raises $40 Million 3/16/2017
Innovus Pharma Announces $3.85 Million Public Offering 3/16/2017
Ally Bridge Backs $301 Million Privatization Of Luoxin Pharma 3/16/2017
Immune Therapeutics Further Strengthens Balance Sheet As It Prepares For Commercialization 3/16/2017
New Investors Back Bay Area Firm Moximed's $50 Million Funding Round 3/16/2017
Massachusetts' Corindus Vascular Robotics Reels in $45 Million 3/16/2017
Massachusetts' RenalGuard Grabs $15 Million Series A 3/16/2017
Active Implants Locks in First Tranche of a $40 Million Equity Financing 3/16/2017
The Lone Star State's Peloton Therapeutics Banks Another $22.2 Million, Bringing Its Total Raise to $74.6 Million 3/15/2017
3 Dazzling Biotechs Poised to Soar Even More 3/15/2017
Bernie Sanders: Trump Must Stop Sanofi (SNY)'s Exclusive Zika Deal 3/15/2017
Bill & Melinda Gates Foundation Alums Rake In $200 Million Biotech-Healthcare Fund Dubbed Biomatics Capital 3/15/2017
This Pharma Tripled Investors' Cash Over The Past Year 3/15/2017
Autifony Therapeutics Obtains £1.3 Million In Funding From Innovate UK And The Dementia Discovery Fund To Explore Novel Approach To Treatment Of Dementia 3/15/2017
TRACON Pharma (TCON) Announces $21 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC 3/15/2017
Dementia Consortium Funds Manchester Based Team Targeting Immune System In Search For New Dementia Treatments 3/15/2017
Feinstein Institute Scientist Awarded $3M for Schizophrenia Research 3/15/2017
Captozyme Secures $3.4 Million To Continue Enzyme Research 3/15/2017
Boston's 908 Devices Nabs $20 Million 3/15/2017
Ackman Is Finally Done With Valeant (VRX), Takes $2.8 Billion Loss and Will Step Down From Board 3/14/2017
2 Biotechs That Could Vanish by 2019 3/14/2017
Mid-South Soybean Breeding Gets $6 Million Boost From Bayer (BAY) 3/14/2017
Bay Area's Cardiva Med Banks $30 Million 3/14/2017
CellAegis Devices Inc. Announces US$9.5 Million Financing To Support Clinical And Regulatory Advancement Of Its autoRIC Device 3/14/2017
Why This Biotech Has Amazon (AMZN)-Growth Potential 3/13/2017
3 Under-the-Radar Biotech Stocks to Check Out in March 3/13/2017
HistoSonics Appoints Mike Blue As CEO And Board Member; Completes First Close Of A Series B Financing 3/13/2017
Valeant (VRX) Receives Lender Consent For Refinancing And Amendment Of Credit Agreement 3/13/2017
Benitec (BLT.AX) Completes Second Tranche Placement To Nant Capital To Raise A$5.45 Million 3/13/2017
Bio-Rad (BIO) Initiates Long Term Financial Guidance; Commits To Defining Long Term Capital Allocation Targets And Hosting An Annual Investor Day 3/13/2017
3 Biotechs Under $5 With Jaw-Dropping Growth Potential 3/10/2017
How The Repeal Of Obamacare Could Put $270 Million Back In Gilead (GILD)'s Bank Account 3/10/2017
Medin Successfully Recapitalizes And Raises New Capital With Financial Partner 3/10/2017
Battered Biotech Teva (TEVA) Is a Smart Contrarian Buy Now 3/9/2017
3 Little-Known Biotechs That Could Double Overnight 3/9/2017
President Trump Tosses Tweet-Bomb at Drug Industry, Stocks Drop 3/9/2017
Breath Therapeutics Holding BV Spins Out of PARI Pharma With $46 Million and a Ready-to-Go Phase III Drug/Device Combo 3/9/2017
OncoResponse Announces Final Closing Of $22.5M Series A Financing Round 3/9/2017
Arrhythmia Research Technology, Inc. (HRT) Reports Company Name And Ticker Symbol Changes 3/9/2017
BeyondSpring Pharmaceuticals Prices Initial Public Offering And Concurrent Private Placement Of $54.31 Million 3/9/2017
Inhibikase Therapeutics Awarded $433,000 From Inhibikase Therapeutics To Advance Development Of Kinase Inhibitor Treatment For Parkinson's Disease 3/9/2017
A Closer Look at GRAIL, Illumina (ILMN)'s Billion-Dollar Bay Area Diagnostics Startup 3/9/2017
Hubble Raises $16.5 Million To Deliver Affordable Daily Contact Lenses 3/9/2017
3 Things Gilead (GILD) Can Do To Return To Its Glory Days 3/8/2017
Backed by Google (GOOG), Cambridge's Spero Nabs $51.7 Million Series C 3/8/2017
Third Rock Ventures Quietly Launches Tango Therapeutics in Editas Medicine (EDIT)’s HQ 3/8/2017
New Jersey's Braeburn Pharma Secretly Funded Advocacy Group Fronted By Newt Gingrich 3/8/2017
Virta Health Launches in the Bay Area With $37 Million 3/8/2017
World's Richest Doctor Accused of Diverting Donations Back to His Own Companies 3/8/2017
Why Ionis Pharma (IONS)'s Extensive And Deep Pipeline Could Get Investors' Hearts Pumping 3/8/2017
Kadmon Announces Approximately $23 Million Equity Financing 3/8/2017
Fibrocell (FCSC) Announces Convertible Preferred Stock Financing For $8 Million 3/8/2017
Zomedica Announces Ongoing Equity Financing 3/8/2017
Science Center’s Digital Health Accelerator Accepting Applications For Third Class 3/8/2017
Frontline Bioventures Closes Second China RMB Life Science Fund 3/8/2017
ImmunoMet Therapeutics Raises $5 Million in a Series B Financing 3/8/2017
SoCal's VertiFlex Bags $40 Million 3/8/2017
Bay Area's Velano Vascular Rakes In $17 Million for Needle-Free Blood Draw Device 3/8/2017
Why Pharma Giant AstraZeneca PLC (AZN)'s Market Value Gained $3.8 Billion Last Month 3/7/2017
2 Tempting Biotech Stocks to Avoid Like Mad 3/7/2017
Airway Therapeutics, LLC Closes $6.3M In Finance Round 3/7/2017
Avadel Pharma (FLML) Announces $25 Million Share Repurchase Program 3/7/2017
Zivo Bioscience, Inc. Executes Debt Restructuring With Private Equity Firm Hep Investments, LLC 3/7/2017
Pacira (PCRX) Announces Proposed Offering Of $300 Million Aggregate Principal Amount Of Convertible Senior Notes 3/7/2017
Cincinnati's Airway Therapeutics Bags $6.3 Million 3/7/2017
2 Pharma Stocks That Billionaires Piled Up On Recently 3/6/2017
Why This Alzheimer's Biotech May Not Live to See 2020 3/6/2017
Filings Reveal Billionaire Super-Investor Stocked Up on These 2 Biotech Stocks 3/6/2017
InGeneron Completes Strategic Financing From Sanford Health To Advance Regenerative Cell Therapies 3/6/2017
NxThera Nabs $14.6 Million in New Funding Round 3/6/2017
Backed by Amazon (AMZN) and Big Names Like Bristol-Myers Squibb (BMY), Celgene (CELG) and Merck & Co. (MRK), Bay Area's GRAIL Banks $900 Million 3/3/2017
OrbiMed To Raise $450 Million For Third Asia Life Science Fund 3/3/2017
OrbiMed Bets Big On Asia Biotechs With $450 Million Fund 3/3/2017
Is This The Best Biotech Play For 2017? 3/3/2017
Easton Pharmaceuticals (OP: EAPH) Announces The Closing Of A Financing Facility With Additional Financing Commitments; Provides Other Updates 3/3/2017
Alere (ALR)'s Bad News Tests The Limits Of Everyone's Patience 3/3/2017
Colorado's Surefire Bags $12.8 Million Series D 3/3/2017
Avoid These 3 Biotech Stocks Like the Plague 3/2/2017
Sofinnova Partners Raises €106 Million In A First Closing Of Its Industrial Biotech Fund 3/2/2017
Massachusetts' CardioFocus Nabs $20 Million, Seeks $12 Million More 3/2/2017
Why The 'New Valeant (VRX)' Feels And Looks Like The Old One 3/1/2017
28-Year Old's Bay Area Startup Freenome Just Landed $65 Million 3/1/2017
OMEICOS Therapeutics Announces First Closing Of €8.3 Million Series B Financing Round And The Initiation Of Phase 1 Clinical Trial 3/1/2017
Comet AG Biorefining Completes Equity Financing 3/1/2017
Congenica Raises £8M ($10M) In Series B Financing Round To Drive International Expansion Of Its Genome Analysis Business 3/1/2017
Alere (ALR) Informs Abbott (ABT) of New Asia Accounting Snafu, Delays Filing Annual Report 3/1/2017
Motus Nabs $30 Million 3/1/2017
ULURU Announces Strategic Financing Agreement 3/1/2017
Time Might be Running Out to Buy These 3 Biotech Stocks at a Discount 2/28/2017
CRISPR/Cas9 Startup Exonics Therapeutics Launches in Boston 2/28/2017
How President Trump's 2018 Budget Will Affect Science Programs 2/28/2017
Biotech Vets Launch Arrakis Therapeutics With $38 Million and Will be Helmed By Biogen (BIIB) Alum Michael Gilman 2/28/2017
Rich Pharma Attracts New Financing Package With GHS Investments, LLC 2/28/2017
Addex Therapeutics (ADXN.SW) Raises CHF3.0 Million Through Private Placement Of Treasury Shares And Extends Cash Runway Through 2018 2/28/2017
Boston Scientific (BSX) Gets in on Corindus Vascular Robotics's $45 Million Funding Round 2/28/2017
Colorado's Muse bio Secures $23 Million Series B 2/28/2017
This One Small-Cap Biotech Could Make You Rich 2/27/2017
Buyers Remorse: Merck & Co. (MRK) Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix (IDIX) Buy 2/27/2017
Pharma Two B Ltd. Closes $30 Million Financing Round 2/27/2017
Parkinson's Disease Foundation Invests $500,000 In Community-Driven Clinical Research To Ease Cognition, Sleep And Fatigue In Parkinson's 2/27/2017
Why This 11-Employee Massachusetts Biotech's Market Cap Doubled Yesterday 2/24/2017
Backed by Johnson & Johnson (JNJ), Fusion Pharma Launches With $25 Million 2/24/2017
The End of the Road: New Jersey's NovaDel Pharma (NVD) to Dissolve 2/24/2017
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Invests $2 Million In Adgero Biopharmaceuticals Holdings, Inc. Of The U.S. 2/24/2017
DMD Therapeutics Receives Funding From DMD Foundations To Develop DMD-813 For Treatment Of Duchenne Muscular Dystrophy 2/24/2017
Xenex Locks in $38 Million in Funding 2/24/2017
2 Biotechs That Had a Rough 2016 But May Be Poised for a Turnaround This Year 2/23/2017
3 Overlooked Biotechs That Deserve More Attention 2/23/2017
Serial Investor Carl Icahn Takes Stake in Bristol-Myers Squibb (BMY), Stock Jumps 2/23/2017
Hong Kong's Ally Bridge Invests In Two European Biopharmas 2/23/2017
BioDelivery (BDSI) Secures Debt Financing With CRG 2/23/2017
TL Biolabs Announces $4 Million In Funding Led By Andreessen Horowitz 2/23/2017
Bristol-Myers Squibb (BMY) Prices $1.5 Billion Of Senior Notes 2/23/2017
This Tiny Biotech Grew 412% in 2016. A Look at Whether It Can Continue in 2017 2/22/2017
New Jersey's PMV Pharma Rakes In $74 Million for Cancer Drugs Targeting P53 2/22/2017
Pfizer (PFE) Abandons European Listings Due To Liquidity Issues 2/22/2017
4 Biopharma Stocks a Billionaire Investor Just Bought 2/22/2017
Oncternal Therapeutics Closes $18.4 Million Series B Financing 2/22/2017
Apollo Therapeutics Funding Of Four Initial Projects And Operational Update 2/22/2017
Global Blood Therapeutics (GBT) Prices A $125.0 Million Upsized Common Stock Public Offering 2/22/2017
Helix Biopharma (TSX:HBP) Release: 30 Million CAD$ Investment In European Centre Of Cancer Immunotherapy 2/22/2017
Rumored Acquisition Target Bristol-Myers Squibb (BMY) Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback 2/21/2017
Why Biotech Looks Like A Good Bet In 2017 2/21/2017
The 10 Biggest Losers in Biopharma Last Year 2/21/2017
How Much Money Embattled Theranos Has Left in the Bank 2/21/2017
Affigen Announces $17 Million Series A Led By Black Beret Life Sciences 2/21/2017
iBIO Institute’s PROPEL Startups Raise $80 Million In 2016, Total Capital Raised Now $265 Million 2/21/2017
Massachusetts' Medrobotics Closes $20 Million to Expand Into General Surgery and Build Next Generation Robot System 2/21/2017
Modus Raises SEK 32 Million To Support Development Of Sevuparin For Sickle Cell Disease 2/20/2017
Centauri Therapeutics Closes £2.5 Million Fundraising 2/20/2017
Minnesota's Skyline Medical Compliant With All Nasdaq Listing Criteria Once Again 2/20/2017
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug 2/17/2017
Why Investors Are Betting Big Against Gilead (GILD)'s Possible Acquisition Candidate Intercept Pharma (ICPT) 2/17/2017
How Bristol-Myers Squibb (BMY) And Pfizer (PFE) Are Stomping On Their Blood Thinner Rivals 2/17/2017
3 Biotech Stocks To Put In Your Investment Portfolio This Month 2/17/2017
New SoCal Biotech Jecure Therapeutics Makes Debut and Will Take on NASH 2/17/2017
A Look at Whether AbbVie (ABBV) Could Eventually Face the Same Issues as Gilead (GILD) 2/17/2017
3 Biotech Stocks Rookie Investors Should Check Out 2/16/2017
Trump Plans to Slash $6 Billion From the NIH 2/16/2017



//-->